An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
Julian SureyH R StaggT A YatesM LipmanP J WhiteA CharlettL MuñozL GosceM X RangakaM FrancisV HackH KunstI AbubakarPublished in: BMC infectious diseases (2021)
The trial was funded by the NIHR, UK and registered with ISRCTN ( 26/02/2013-No.04379941 ).